Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2024 Earnings Call Transcript
Operator: Hello and welcome to the Adaptimmune Therapeutics Third Quarter 2024 Results Conference Call. As a reminder, all participants are in listen-only mode, and the conference is being recorded.